IMPORTANT DISCLAIMER: EDUCATIONAL PURPOSES ONLY. This post is for educational and informational purposes only. It is not investment advice and not financial advice, and it is not a recommendation to buy, sell, or hold SPCX, TSLA or any other security. Do your own research and consult a licensed financial advisor before making any investment decision. Investing involves risk, including the possible loss of your money.

CNBC Television: "SpaceX rises in premarket after earnings beat and Musk hints at Tesla tie-up". Facts on this page cite the primary sources below, not the video.

Honest fence (read first): SpaceX (Nasdaq: SPCX) reported Q3 results after the close on Tuesday, Oct 20. We covered the results themselves in a separate post and won't repeat them here. This post is about what happened after: the analyst target changes on Oct 21 and 22, the Oct 22 lock-up release of up to 1.3 billion shares, the price and volume those days, and the 10-Q SpaceX filed Thursday night. Prices come from StockAnalysis (Friday's intraday quote from Nasdaq.com). Analyst targets come from CNBC and the StockAnalysis/TipRanks ratings table. Friday's Oct 23 intraday price will have moved by the time you read this.

Editorial Thesis

In one week, SPCX investors got three signals that seemed to point in different directions. Analysts raised their targets, some by a lot. The stock jumped almost 8% on Wednesday and then gave all of it back, and more, on Thursday. And the biggest batch of insider shares so far became sellable on the same day it fell. The lesson for a learner isn't "the analysts were wrong" or "the unlock crushed it." It's that these are different kinds of information: a target is an opinion about 12 months from now, an unlock is a change in who's allowed to sell, and a day's price move has many causes, including the whole market. Keeping them apart is the skill.

Honest Verdict

Proven (data and filings): the Oct 21 and Oct 22 closes and volumes; the analyst target changes as reported by CNBC and TipRanks; the 10-Q's share count and its language on a possible Tesla combination; the prospectus unlock schedule as summarized by outside trackers. Opinion: every price target, and every explanation of why the stock fell. Unknown: how many of the newly eligible shares were actually sold. Volume counts all trades, not just insiders, and sellers don't report on day one.

What the stock did (StockAnalysis daily data)

Day What happened Close Change Volume
Tue Oct 20 Q3 results after the close $147.79 -0.11% 90.4M
Wed Oct 21 First session after results $159.31 +7.79% 217.4M
Thu Oct 22 Lock-up release day (up to 1.3B shares) $144.75 -9.14% 197.0M

A few things worth noticing, using our own math on those numbers:

  • Thursday's close of $144.75 was $3.04 (about 2.1%) below the pre-results close of $147.79. The whole post-earnings gain was gone in one session.
  • On Wednesday, SPCX traded as high as $166.18. Thursday's low was $143.21.
  • Thursday's volume of 197 million shares equals about 15% of the up-to-1.3 billion newly eligible shares. That doesn't mean 15% of them sold. It just shows the scale.
  • For context, SPCX closed at $171.92 on Oct 6. Thursday's close is about 16% below that. The IPO price was $135 on June 12.

It wasn't only SpaceX. The Nasdaq fell 2.6% on Thursday, and a SpaceNexus index of space stocks fell 3.1%, with 33 of 35 names down. The Closing Print described the peer selloff as tracking "a broad risk-off day rather than a SpaceX-specific spillover." That's one outlet's read, but it's a useful reminder that a single day's move usually has more than one cause.

After hours and this morning: SPCX rose 1.17% to $146.44 after the close Thursday, after Bloomberg reported that SpaceX is in talks to access at least 80,000 US cell sites (a Starlink story we'll look at separately). Friday morning, Nasdaq.com showed SPCX at $147.40, +1.83% (+$2.65), at 11:27 AM ET, in a day range of $144.08 to $149.75 so far. That's a live intraday price and will have moved by the time you read this.

What the analysts did (Oct 21 to 22)

These are 12-month price targets from firms that cover SPCX. Upside is our math against Thursday's $144.75 close.

Firm (analyst) Rating Old to new target Upside vs $144.75 Source
JPMorgan (Doug Anmuth) Overweight $240 to $500 +245% CNBC
Barclays (Anthony Valentini) Overweight $254 to $300 +107% CNBC
Morgan Stanley Overweight $300 (kept) +107% CNBC
BofA (Ronald Epstein) Buy $235 to $275 +90% TipRanks/StockAnalysis
Wells Fargo Overweight $214 to $274 +89% CNBC
Pivotal Research (Jeffrey Wlodarczak) Buy $230 to $260 +80% TipRanks/StockAnalysis
Goldman Sachs (Eric Sheridan) Buy $230 to $245 +69% TipRanks/StockAnalysis
Citi Buy $200 to $240 +66% CNBC
UBS Buy $210 to $230 +59% CNBC
RBC (Kenneth Herbert) Buy $225 (kept) +55% TipRanks/StockAnalysis
Mizuho (Brett Linzey) Buy $200 to $205 +42% TipRanks/StockAnalysis
DZ Bank (Markus Leistner) Sell kept, no target listed n/a TipRanks/StockAnalysis

The consensus: StockAnalysis, using S&P Global data from 38 analysts, lists an average target of $222.71, a median of $225, a high of $450 and a low of $118. That's about 18% below Thursday's close. (The $450 high hasn't caught up with JPMorgan's new $500, which shows how these databases lag.) LSEG data cited by CNBC counted 33 of 43 analysts at buy or strong buy.

What the bulls said. JPMorgan's Anmuth: "SpaceX's ambitions are bigger than any company's we've seen." Barclays' Valentini said SPCX "is proving the durability of its AI revenue growth." Morgan Stanley put it at about 15.7 times its new 2028 earnings estimate of $9.45 a share, using a $160 post-market price. All of these are views about the future, not facts about the company.

How to read a target. A price target is one analyst's estimate of where the stock could trade in about a year, built on their own model. It's not a prediction of next week, and it's not a promise. Targets also tend to move after prices move. Notice that a 9% drop on Thursday didn't change a single target in the table. That's normal, and it's why a target is a poor timing tool.

What unlocked, and what's next

SpaceX's IPO lock-up doesn't end all at once. Under the prospectus schedule, as transcribed by outside trackers and The Closing Print:

  • Thu Oct 22: up to 1.3 billion shares, 28% of the shares in the 180-day lock-up pool, released on the second full trading day after Q3 results. That's about 9.6% of all shares, the largest batch so far.
  • Sat Oct 24: up to 328.4 million more. The first session they can trade is Monday, Oct 26.
  • Tue Dec 8: the remainder of the 180-day pool, up to 797.6 million.
  • June 12, 2027: Elon Musk's roughly 6.4 billion shares, which have a separate 366-day lock-up with no early release.

We walked through this calendar on Oct 14. The new information is how the stock behaved on the big release day. One honest caution: eligible to sell is not the same as sold. Fool's analysis of an earlier release, which we cited on Oct 14, found about 73 million shares traded on a day when 328.4 million became eligible. Insiders' actual sales only show up gradually, in filings and in volume patterns over weeks.

What the 10-Q added

SpaceX filed its quarterly report with the SEC on Thursday evening, at 8:03 PM ET. Two items matter here.

1. The share count. "As of October 15, 2026, the registrant had 8,246,541,218 shares of Class A common stock and 5,334,522,491 shares of Class B common stock outstanding." That's about 13.58 billion shares in total. At $144.75, that's a market value of about $1.97 trillion across both classes (our math).

2. The Tesla question. The filing confirms that SpaceX's board formed a special committee to evaluate "a potential combination between SpaceX and Tesla," and that Tesla's board formed one too. Then the key sentence: "No determination by our special committee has been made regarding any potential combination, and any potential combination would be subject to further approval by our special committee, our board of directors and our controlling shareholder." The controlling shareholder is Musk. Reuters summarized it as SpaceX disclosing that a merger "will require approval from its controlling investor." The 10-Q also says "there can be no assurance that any agreement will be reached." There's no deal, no terms and no timeline.

Claim vs proof

Claim you may hear What the evidence shows
"Analysts say SPCX is going to $500" One firm (JPMorgan) set a $500 12-month target. The consensus average is $222.71; the low is $118.
"The unlock crashed the stock" SPCX fell 9.14% on the release day, alongside a 2.6% Nasdaq drop and broad space-stock weakness. How much insiders sold is unknown.
"The worst of the unlocks is over" The biggest batch has passed, but 328.4M more can trade Oct 26, up to 797.6M on Dec 8, and Musk's ~6.4B in June 2027.
"A Tesla merger is coming" The 10-Q says no determination has been made and any deal needs the committee, the board and Musk's approval.

What to watch next

  • Mon Oct 26: first trading session for the next 328.4 million eligible shares.
  • Form 4 and Form 144 filings from insiders, which show actual sales over time.
  • Target changes after the drop, especially any downgrades.
  • Tue Dec 8: the last 180-day release.
  • Any Tesla to SpaceX filing that moves past "evaluate."

Video note

CNBC's 89-second clip (Xe05v7ETk6A, uploaded Oct 21 at 9:45 AM ET) captures Wednesday's pre-market jump and Musk's merger comment. That's the "before" half of this story. Thursday's reversal is the "after." Schwab Network's Oct 22 segment (3B1QB5GYOHk) lays out a bull and a bear case on the merger idea, if you want both sides.

Bottom Line

Proven (data and filings): the Oct 21 and Oct 22 closes and volumes; the analyst target changes as reported by CNBC and TipRanks; the 10-Q's share count and its language on a possible Tesla combination; the prospectus unlock schedule as summarized by outside trackers. Opinion: every price target, and every explanation of why the stock fell. Unknown: how many of the newly eligible shares were actually sold. Volume counts all trades, not just insiders, and sellers don't report on day one.

Disclaimer: Educational Purposes Only

This post is for educational and informational purposes only. It is not investment advice, not financial advice, and not a recommendation to buy, sell, or hold SPCX, TSLA or any other security. Estimates, price targets and options figures belong to the firms and sources named, not to AI Shift News. AI Shift News is not a registered investment advisor. Do your own research and consult a licensed financial advisor before making any investment decision. Investing involves risk, including the possible loss of your money. Past performance and company claims are not guarantees of future results.

Sources